There is a new study drug called Aztreanam Lysine for inhalation. Gilead Science has been attempting to get it FDA approved and has run into a few snags. It is the same antibiotic as what we have seen via IV; however, it is obviously in a different form for inhalation. It is also delivered via e-flow which gives a much higher concentration of the drug directly into the lungs.
The expanded access program is being offered and, if you qualify, you will receive the drug and the e-flow at no cost. You have to meet certain criteria as well as find a center participating that is a reasonable drive for you. I encourage you to check out the website.
There has been a back order on IV aztreanam for quite some time. I am not sure why that has been happening.